Clinical Trial Update: Study of High Efficient Killing Cell Therapy for Advanced NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a high-efficiency killing cell therapy for advanced non-small cell lung cancer is currently recruiting. No efficacy results are repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• High Efficient Killing Cell Therapy

Snippet

Sponsor: Ruijin Hospital | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING